PainChek Limited (PCK.AX)

0.0300 0.0000 (0.00%) As of 10:29AM AEST. Market open.

PainChek Limited

35 Lime Street
Suite 401
Sydney, NSW 2000
Australia
61 4 2125 2123
https://www.painchek.com

Sector(s): Healthcare
Industry: Health Information Services
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Philip Daffas B.Sc., Dip EENG, GAICD, M.B.A.	MD, CEO & Director	286k	N/A	N/A
Mr. Iain McAdam	Chief Financial Officer	277.51k	N/A	N/A
Mr. Andrew Hoggan	Manager & Head of Operations	N/A	N/A	N/A
Mr. Scott Robertson M.B.A.	Chief Technology Officer	N/A	N/A	N/A
Prof. Jeff Hughes Ph.D.	Chief Scientific Officer	N/A	N/A	N/A
Mr. David Allsopp	Head of Business Development	N/A	N/A	N/A
Ms. Natalie Climo	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia and internationally. The company offers PainChek, which uses camera in smartphones and tablets for facial scan that is analyzed in real time using facial recognition software to indicate the presence of the pain. It serves patients suffering with dementia and pre-verbal infants. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.

Corporate governance

PainChek Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.